Doctors believe the treatment prevented more than 1200 heart attacks and strokes in the first year alone.
The results in the American Journal of Managed Care could have widespread implications for the future treatment of heart disease and diabetes.
Study finds promise against heart attacks, strokes
October 2, 2009 Researchers at Kaiser Permanente followed more than 65,000 patients and gave them a bundled treatment consisting of Lovastatin, a common cholesterol lowering drug, and Lisinopril, a blood pressure drug. Also included in the mix was a low-dose aspirin.
